Antibodies
11 April 2014
PolyTherics and MacroGenics Extend Collaboration to Produce Novel Antibody Drug Conjugate11 April 2014
Precision Biologics’ NEO-102 Continues to Show Encouraging Results in Pancreatic and Colorectal Cancer Patients9 April 2014
ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN8537 April 2014
Immunomedics Reports Results From Three Phase I Trials With IMMU-130 in Metastatic Colorectal Cancer7 April 2014
Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technology Advances at AACR7 April 2014
Mersana Therapeutics Enters Collaboration with Takeda to Develop Next-Generation Antibody-Drug Conjugates3 April 2014
Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic Microangiopathies2 April 2014
Synthon’s Anti-HER2 ADC Frontrunner SYD985 Outperforms Only Available HER2-targeting ADC1 April 2014
Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports